Trial intelligence / Profile preview

Sirolimus and Cyclosporine in Refractory Aplastic Anemia

NCT00319878Phase 2Unknown

Sponsor
Office of Rare Diseases Research
Start
May 2006
Primary completion
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sirolimus in aplastic anemia, sponsored by Office of Rare Diseases Research. Status: unknown.

02

Drugs

sirolimus
03

Conditions

aplastic anemia

Beyond the preview

Go deeper on NCT00319878.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00319878.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call